Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake-Reference-Cited by-同舟云学术

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake

Published:2021-04 Issue: Volume:160 Page:103299
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

De Toma Alessandro,Lo Russo Giuseppe,Signorelli Diego,Pagani Filippo,Randon Giovanni,Galli Giulia^ORCID,Prelaj Arsela^ORCID,Ferrara Roberto,Proto Claudia,Ganzinelli Monica,Zilembo Nicoletta,de Braud Filippo,Garassino Marina Chiara

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference205 articles.

1. Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer;Adachi;Carcinogenesis,2017

2. SWOG S1400D (NCT02965378), a phase II study of the fibroblast growth factor receptor inhibitor AZD4547 in previously treated patients with fibroblast growth factor pathway-activated stage IV squamous cell lung cancer (Lung-MAP substudy);Aggarwal;J. Thorac. Oncol.,2019

3. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas;Arcila;Clin. Cancer Res.,2012

4. ALK inhibitors in non-small-cell lung cancers: crizotinib and beyond;Awad;Clin. Adv. Hematol. Oncol.,2014

5. Aquired resistance of crizotinib from a mutation of CD74-ROS1;Awad;N. Eng. J. Med.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT1 receptor to promote lung adenocarcinoma growth;Journal of Advanced Research;2022-11

2. Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications;Genes, Chromosomes and Cancer;2022-01-22

3. LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-β1/Smad/Snail Pathway;Canadian Respiratory Journal;2021-12-06

4. Systemic Therapy for Lung Cancer Brain Metastases;Current Treatment Options in Oncology;2021-10-25

5. What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy;Journal of Molecular Pathology;2021-06-04